Ensysce Biosciences Inc (ENSCW) financials · rev $5.2M
Ensysce Biosciences Inc (ENSCW) rev $5.2M.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $5.2M | $2.2M | $2.5M | $3.5M |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 | $0 |
| Net Income | -$8.0M | -$10.6M | -$24.2M | -$29.1M |
| EPS (Diluted) | $-11.45 | $-70.40 | $-139.42 | $-1.48 |
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Total Assets | $5.6M | $2.7M | $5.9M |
| Current Assets | $0 | $0 | $0 |
| Cash & Equivalents | $3.5M | $1.1M | $3.1M |
| Inventory | $0 | $0 | $0 |
| PP&E | $0 | $0 | $0 |
| Total Liabilities | $2.2M | $3.4M | $9.9M |
| Current Liabilities | $0 | $0 | $0 |
| Short-term Debt | $0 | $0 | $0 |
| Long-term Debt | $0 | $0 | $0 |
| Total Debt | $0 | $0 | $0 |
| Shareholders' Equity | $0 | $0 | $0 |
| Retained Earnings | $0 | $0 | $0 |
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Operating Cash Flow | -$7.5M | -$10.8M | -$17.9M | -$8.2M |
| CapEx | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $4.5K | $0 |
| Financing Cash Flow | $9.9M | $8.8M | $8.8M | $20.3M |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Net Change in Cash | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |
FAQ
What is ENSCW P/E and revenue?
Ensysce Biosciences Inc (ENSCW) rev $5.2M.
What is ENSCW revenue?
Ensysce Biosciences Inc last cached revenue is $5.2M (FY2024).
Is ENSCW profitable?
Ensysce Biosciences Inc last cached net income is -$8.0M.
What are ENSCW total assets?
Ensysce Biosciences Inc last cached total assets are $5.6M.
What is ENSCW free cash flow?
Ensysce Biosciences Inc last cached free cash flow is $0.
Not investment advice. Cached statements, not a live tape.